Viewing Study NCT02105350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-02-25 @ 7:27 PM
Study NCT ID: NCT02105350
Status: WITHDRAWN
Last Update Posted: 2018-02-19
First Post: 2014-04-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Carcinoma View
None Gallbladder Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEK162 View
None Gemcitabine View
None Oxaliplatin View
None Non-resectable View
None Recurrent or metastatic View